Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Highvista Gold Drills at Canasta Dorada Gold Project

Critical Elements, Blue Note Mining Report Initial Results from Croinor Project

Auryx Gold Reported Infill and Exploration Drilling from Otjikoto Project

Argentum Silver Reports Silver Assay Results from Coyote Project

Antioquia Gold Discovers Second Vein System at Cisneros Project

BonTerra Resources Receives Assay Results from Eastern Extension Property

Radisson Mining Resources to Commence Surface Exploration Drilling at O'brien-Kewagama Property

Oracle Mining Reports Further Assay Results from Oracle Ridge Copper Mine

Caza Gold Cuts Wide Gold Mineralization Zone at Balleza Project

Sanatana Resources Receives Positive Channel Sampling Results from Watershed Property

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.